Weight ManagementApply for Access
Tirzepatide
GLP2-TZ — GIP/GLP-1 Dual Agonist
Tirzepatide is a dual GIP and GLP-1 receptor agonist investigated for its synergistic effects on metabolic parameters, body composition, and insulin sensitivity in research models.
Purity
≥99.1%
Form
Lyophilized Powder
Molecular Weight
4813.48 Da
Amino Acid Sequence
Tyr-Aib-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Gly-Lys-Gly-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Pricing & Availability
Available to approved wholesale partners only.
Certificate of Analysis
Tirzepatide
APPROVED
Test Results — Batch #9IL2T5
Identity (HPLC/MS)
Confirmed by MSPASS
Purity (HPLC)
99.1%PASS
Endotoxin (LAL)
< 0.1 EU/mgPASS
Moisture Content
2.1%PASS
Appearance
White Lyophilized PowderPASS
Sterility
No Growth DetectedPASS
Third-Party Verified
Full COA available to partners
Research Applications
- Dual incretin receptor research
- Body composition studies
- Insulin sensitivity research
- Metabolic disease models